Development Office Funding Opportunities

The Development Office’s Corporate and Foundation (C&F) Team identified the below funding opportunities. To apply, please contact DevCorpFound@mountsinai.org. The C&F team will help plan, write, and submit your application.
Crohn’s & Colitis Foundation Senior Research Award Amount: Up to $390,000 over 3 years Deadline:
•LOI due June 2, 2026
•Full proposal due July 23, 2026

Eligibility:

•Applicant must hold an MD and/or PhD (or equivalent degree) and must be employed by an institution (public non-profit, private non-profit, or government) that is engaged in health care and/or health-related research. He/she must have attained independence from his/her mentor.
•Proposal must be relevant to Inflammatory Bowel Disease (IBD) or Crohn’s disease and/or ulcerative colitis. Only one application is allowed per applicant per submission date. Simultaneous submission of a Senior Research Award and a Training Award is not permitted.

About: Provides established researchers with funds to generate sufficient preliminary data to become competitive for funds from other sources such as the National Institutes of Health (NIH). https://www.crohnscolitisfoundation.org/research/grants-fellowships/senior-research-awards
Pfizer: Improving Health Outcomes in Patients with ATTR-CM Through the Development of a Shared Decision-Making Tool (Decision Aid)  Amount:
$250,000 over 1 year  
Deadline: June 3, 2026

Eligibility:

•Health organizations, academia, medical societies, or professional organizations, in partnership with patient advocacy organizations, that include transthyretin cardiac amyloidosis (ATTR-CM) as one of the focus areas are encouraged to apply.

•The PI must have a medical or postdoctoral degree (MD, PhD, or equivalent), an advanced nursing degree (BSN with a MS/PhD), or a degree in Pharmacy, Physiotherapy, or Social Work.

About: This RFP seeks to support medical societies or professional organizations, in partnership with patient advocacy organizations, to develop, validate, and/or evaluate a shared decision-making tool (Decision Aid) aimed at improving decision quality, health outcomes, patient experience, and quality of care among individuals living with ATTR-CM.

Proposals should address all the following areas of interest:

•Tool design and content development consistent with decision-making theory and methodology for SDM tool development and validation.

•Co-development of the tool with stakeholders to ensure relevance, clarity, and acceptability. Input from stakeholders should directly inform content, language, format and practical considerations of the SDM tool. Stakeholders include patients living with ATTR-CM, patient advocacy organizations, caregivers, cardiac amyloidosis specialists such as cardiologists, nurses, and allied HCPs

•Needs assessment and conceptual framework grounded in bidirectional information exchange including literature review and focus groups with stakeholders to identify gaps and decision-making challenges in ATTR-CM care pathway

•Assessment of the tool including tool validity and usability testing with end-users for practical real world clinical use and minimization of unintended barriers to engagement.

https://cdn.pfizer.com/pfizercom/2026-05/GMG-2026-RD-US-CVM-ATTR-CM-SDM-RES.pdf?VersionId=OFED7qW6bT6vAUxGi0cSmSmKgHRU9E3i
AACR Gertrude B. Elion Cancer Research Award 

Amount: $225,000 over 1 years

Deadline:
•LOI due June 4, 2026
•Full proposal due September 16, 2026

Eligibility:

•Have a doctoral degree (including PhD, MD, MD/PhD, or equivalent) in a related field and not currently be a candidate for a further doctoral degree.

•Hold a tenure-eligible appointment (or equivalent, if institution does not follow a tenure system) at the rank of assistant professor (appointments such as research assistant professor, adjunct assistant professor, assistant professor research track, visiting professor, or instructor are not eligible. Applicants cannot be tenured or under consideration for a tenured academic position at the time of the application. Applicants that have progressed to associate professor appointments are also not eligible.)

•Have started their first independent faculty position with the title of assistant professor within the past 6 years from the grant start date

About: With generous support from GlaxoSmithKline, the AACR Gertrude B. Elion Cancer Research Award represents a joint effort to encourage and support tenure-eligible junior faculty. The research proposed for funding must focus on cancer etiology, diagnosis, treatment, or prevention and may be basic, translational, or clinical in nature.

https://www.aacr.org/grants/aacr-gertrude-b-elion-cancer-research-award-2/
AACR-Novocure Cancer Research Grant  Amount: $350,000 over 3 years  Deadline: Proposal due June 4, 2026 

Eligibility:

•Applicants must be AACR Active members who are independent investigators and have a doctoral degree (PhD, MD, MD/PhD, or equivalent) in a related field and not currently be a candidate for a further doctoral degree. 

About: Supports independent investigators who are currently conducting innovative research focused on Tumor Treating Fields (TTFields; intermediate frequency, low intensity, alternating electric fields that disrupt cell division in cancer cells) as well as to encourage independent investigators to enter the TTFields research field. The Inovitro® system (which will be provided by Novocure, if needed), must be included in the experimental design.
Research projects should examine the use of TTFields as a therapeutic modality for cancer. Proposals may include 1) Basic and translational approaches, promoting the transition of TTFields in vitro work into in vivo systems, 2) Studies that link preclinical and clinical data, or 3) Studies with ability to translate into the clinic for cancer treatment.
Projects that focus on one or more of the areas outlined below are strongly encouraged, provided they incorporate the use of Inovitro® and/or inovivo® systems:
• Key cancer-related signaling and cellular pathways.
• Metabolic effects of TTFields.
• Studies that include Omics data (genomics, transcriptomics, proteomics).
• TTFields immunological aspects and the potential combination with immunotherapy.
• Combinational studies with approved agents (preferably to include mechanistic aspects).

AACR-Novocure Cancer Research Grant | Grants| AACR
SPARK NS Translational Research Program  Amount: Stage II Mission Boost: Up to $545,000 over 1.5 yrs  Deadline: June 5, 2026 

Eligibility: —

About: SPARK NS is an independent non-profit translational research organization dedicated to efficiently advancing promising neuroscience discoveries from the lab to the clinic.

For the SPARK NS Translational Research Program, 2026 Cohort, SPARK NS will select academic PIs with therapeutic discoveries in Parkinson’s disease or autism at any stage of development between target identification and entry into clinical trials. For selected projects, SPARK NS will provide funding, education, mentorship, and networking opportunities focused on advancing the translation of novel science to first-in-class therapeutics.

Proposed projects must:
• Address an unmet clinical need in Parkinson’s disease or autism
• Use a robust and novel approach
• Have a high probability of success at accomplishing proposed translational objectives

SPARK NS Call for Proposals
ChadTough Fellowship Grant Amount:
•Predoc – $200,000 over 3 years
•Postdoc – $300,000 over 3 years
Deadline:
•LOI due June 8, 2026
•Full proposal due September 2, 2026

Eligibility:
•For pre-doctoral applicants:
Applicant must be enrolled in a research doctoral degree program at an accredited academic institution.

•For post-doctoral applicants:
Applicant must hold an M.D. and/or Ph.D. by the application deadline.
Applicant must be no more than 6 years post-completion of last degree.

About: The ChadTough Defeat DIPG Fellowship Grant is intended to attract and support promising scientists embarking on careers involving DIPG research. By providing funding to outstanding fellows under the guidance of a mentor, we seek to assist in the development of the next generation of leaders in the field of DIPG research. https://media.chadtough.org/wp-content/uploads/2025/05/06125321/2025-Fellowship-Application-Guidelines-1.pdf
The Jacobs Foundation: LEVANTE  Amount:
•Regular projects: Up to $250,000 over 3 years
•Larger Projects: Up to $600,000 over 4 years
•Infrastructure Projects: Up to $1M over 4 years
Deadline:
LOI due June 10, 2026

Eligibility:

•Have obtained a PhD or equivalent degree at least 5 years (excluding career breaks) prior to the application deadline; 

•Be employed by and be part of a research lab at an institution of higher education or research institute;

•Be conducting high-quality research in the area of variability of learning and development;

•Be committed to engaging with and contributing to the activities of both LEVANTE and the Jacobs Foundation.

About:  The overarching objective of LEVANTE is to identify how individual variability, group heterogeneity, and contextual variability influence children’s learning and development. By including data collection of common measures on these different areas longitudinally and at a global level, LEVANTE will help researchers, educators, and policymakers understand child development within individuals, within groups, and across contexts, thus improving future learning outcomes for diverse groups of children worldwide. The focus of the Jacobs Foundation is fostering scientific excellence and building a strong network of internationally active researchers in the field of child and youth development with a strong focus on variability of learning and to foster long-term collaboration with other researchers and the Jacobs Foundation.

This call seeks proposals for research projects that collect longitudinal data using the LEVANTE battery across ages 3–12. Within this framework, special consideration will be given to proposals that

•Contribute to causal inference on mechanisms underlying learning and development, and/or generate insights into how environmental and contextual factors shape learning
•Strengthen the use of innovative, high-resolution measurement approaches and/ or advance our understanding of within-child variability and developmental trajectories

https://levante-network.org/open-call-for-proposals-2026/
AACR-EXELIXIS RENAL CELL CARCINOMA RESEARCH FELLOWSHIP 

Amount: $130,000 over 2 years

Deadline: June 11, 2026

Eligibility:

•Applicants must have a doctoral degree (including PhD, MD, MD/PhD, or equivalent) in a related field and not currently be a candidate for a further doctoral degree.

•At the start of the grant term applicants must:
oHold a mentored research position with the title of postdoctoral fellow, clinical research fellow, or the equivalent
oIf eligibility is based on a future position, the position must be confirmed at the time of submission, and CANNOT be contingent upon receiving this grant.
oIf the future position is at a different institution than the applicant’s current institution, the applicant must contact AACR’s Research and Grants Administration Department (AACR’s RGA) at grants@aacr.org before submitting their application for information on additional verification materials/signatures that may be required.
oHave completed their most recent doctoral degree within the past 5 years (i.e., degree cannot have been conferred before September 1, 2021; the formal date of receipt of doctoral degree is the date the degree was conferred, as indicated on your diploma and/or transcript)
oApplicants with a medical degree must have completed their most recent doctoral degree or medical residency – whichever date is later – within the past five years.
oWork under the auspices of a mentor at an academic, medical, or research institution anywhere in the world.

About: Supports a postdoctoral or clinical research fellow to conduct renal cell carcinoma research and to establish a successful career path in this field. The research proposed for funding may be in basic, translational, clinical, or population sciences research and must have direct applicability and relevance to renal cell carcinoma

https://www.aacr.org/grants/aacr-exelixis-rcc-fellowship/
American Society of Transplantation: Transition to Independence Research Grants Amount: Up to $150,000 over 2 years 

Deadline: June 15, 2026

Eligibility:
The applicant (MD, PhD, PharmD, or equivalent) must hold an academic faculty appointment and be developing an independent research program
Applicants cannot be a PI on a previous or current NIH grant to perform independent research.
Applications are accepted in basic, clinical, and translational research. Only applications supporting research directly related to solid organ transplantation will be considered.

About: The purpose of the AST Research Network Transition to Independence Research Grants is to promote the careers of academic investigators whose development of an independent research program is focused on the field of basic science, translational and clinical investigation in solid organ transplantation. The grants are intended to provide support for the investigator’s transition to an R-series or equivalent grant. The Transition to Independence Research Grant seeks to:
•Foster the transition of early to mid-career scientists who are contributing to our understanding of transplant science/immunobiology and/or treatment of transplant recipients and need funding to start or strengthen work that is not yet funded by larger grants.
•Foster research that is of high merit.
•Encourage the continued commitment of high-quality applicants to careers in academic transplantation About: Postdoctoral Fellowships (PF) support new investigators in research training programs to position them for independent careers in cancer research. As part of their evaluation, peer reviewers consider how well the fellowship will broaden the applicant’s research training and experience.  
https://www.myast.org/grant-opportunities/transition-independence-grants
Glaucoma Research Foundation: Shaffer Grant for Innovative Research  Amount: Up to $55,000 over 1 year

Deadline:
• LOI due July 15, 2026
• Full proposal deadline TBD

Eligibility:

• Grant applicants must possess a graduate degree
• Must not have received a Shaffer Grant within the prior three years

About: Supports young investigators with new perspectives to treat and cure glaucoma. There are two primary focus areas that this grant will fund:

1.Physiology of Glaucoma: May include projects to protect and restore the optic nerve, accurately detect glaucoma and monitor its progress, provide better understanding and treatment for congenital/juvenile glaucoma, understand the intraocular pressure system and develop better treatments, and determine the risk factors for glaucoma damage using systematic outcomes data.

2.Genetics of Glaucoma: May include projects to identify the genes that cause glaucoma and explore new approaches to gene therapy to preserve or restore vision 

Apply For A Grant – Glaucoma Research Foundation
LAM Foundation Pilot and Feasibility Grant Amount:  $100,000 Deadline:
•LOI due June 15, 2026
•Full proposal due September 15, 2026

Eligibility:

An applicant may be a postdoctoral research fellow, postgraduate medical trainee, junior faculty, or established investigator. The LAM Foundation encourages applications from investigators new to LAM research who could contribute their knowledge and expertise.

About: This pilot award provides funds to encourage the development and testing of new hypotheses and/or new methods in research areas relevant to LAM. The proposed work must be hypothesis generating or hypothesis testing, reflecting innovative approaches to important questions in LAM research or development of novel methods, and providing sufficient preliminary data to justify the Foundation’s support. Results from Pilot and Feasibility Grants should have the potential to lead to the submission of applications for funding from other agencies (e.g., NIH). The award is not intended to support the continuation of programs initiated under other granting mechanisms. https://www.thelamfoundation.org/investigators/funding-opportunities/
LAM
LAM Foundation Clinical Research Grant
Amount: $50,000 over 1 years Deadline:
•LOI due June 15, 2026
•Full proposal due September 15, 2026

Eligibility:

•An applicant may be a clinical fellow, clinical instructor, postdoctoral research fellow, postgraduate medical trainee, junior faculty or established investigator.

About: This clinical pilot award generates hypothesis-driven, clinically focused patient centered research that could improve our understanding of novel therapeutic areas of interest, test interventions, or develop clinical research methodologies. The grant is designed to enable research that has the potential to improve an unmet clinical need relevant to the care of LAM patients. A successful application must be feasible within one year and should have a high probability of generating tangible results, such as larger clinical trials, new approaches to or methods to analyze clinical trials, or new data that could be utilized in a natural history database. https://www.thelamfoundation.org/investigators/funding-opportunities/
Research to Prevent Blindness Physician-Scientist Award  Amount: $300,000 over 2 years  Deadline:
• Nominations due June 15, 2026
• Full proposal due July 1, 2026

Eligibility:

Department Chairs (including interim or acting Chairs) from any institution of higher education in the U.S. may nominate multiple candidates per department.
Though multiple candidates can be nominated from one department, only one award per department can be approved.
Candidates must hold a primary academic position as Associate Professor through full Professor (MD, PhD, or MD/PhD) with a primary appointment in a basic science or other relevant department.
Previous recipients of this grant are ineligible.
Candidates must be full-time faculty in their primary appointment department.
Proposed research cannot be funded – previously or currently – by others (NEI, NIH, nonprofits, private funders, etc.).
Candidates declined for this award must wait two years before re-applying for the SI Award. 

About: The RPB Clinician-Scientist Award in Myopia Research will focus on research that seeks to provide a better understanding of the development of myopia and/or how it can be prevented or decelerated. The number of people affected by myopia is now increasing around the world and is projected to affect 50% of the world population by 2050. https://www.rpbusa.org/grants/
Research to Prevent Blindness Stein Innovation Award  Amount: $300,000 over 2 years  Deadline:
• Nominations due June 15, 2026
• Full proposal due July 1, 2026

Eligibility:

Department Chairs (including interim or acting Chairs) from any institution of higher education in the U.S. may nominate multiple candidates per department.
Though multiple candidates can be nominated from one department, only one award per department can be approved.
Candidates must hold a primary academic position as Associate Professor through full Professor (MD, PhD, or MD/PhD) with a primary appointment in a basic science or other relevant department.
Previous recipients of this grant are ineligible.
Candidates must be full-time faculty in their primary appointment department.
Proposed research cannot be funded – previously or currently – by others (NEI, NIH, nonprofits, private funders, etc.).
Candidates declined for this award must wait two years before re-applying for the SI Award. 

About: The RPB Stein Innovation (SI) Awards provide funds to two groups of researchers, both with a common goal of understanding the visual system and the diseases that compromise its function. For the January deadline, Department of Ophthalmology faculty who are performing innovative vision research may apply for the SI Awards. Candidates may be from any institution of higher education in the U.S. For the July deadline, scientists outside the Department of Ophthalmology who are actively engaged in innovative vision research may apply for the SI Awards.  https://www.rpbusa.org/grants/
Samuel Waxman Institute / Mark Foundation: 2026 Request for Proposals for Aging & Cancer Grants  Amount: Up to $500,000 over 3 years  Deadline:
•LOI due June 15, 2026
•Full proposal due September 15, 2026

Eligibility:

•Applicants must have an independent faculty appointment (tenure-track or equivalent) at a non-profit academic/research institution.
•Collaboration teams must consist of one principal investigator (PI) at the host institution and one co-principal investigator (co-PI) at a different institution. We encourage teams that bring together individuals with distinct expertise (e.g. a cancer investigator and computational expert, a cancer investigator and an aging expert who has not previously worked in the cancer field, or experts who study aging in oncology and immunology).
•The PI and co-PI must both lead established laboratories currently supported by multi-year independent funding. For example, for US-based applicants, this should be at least one R01 or R01-equivalent grant. International applicants should similarly demonstrate independent support for their labs.
•Investigators who currently hold “Aging and Cancer” awards from the Mark Foundation are not permitted to apply.
•The PI and co-PI can only participate in one application, regardless of role.

About: Research supported by this program will advance our understanding of the rising incidence of cancer due to aging, with a special emphasis on the role of inflammaging and immunosenescence as common drivers of aging and cancer. Example topics include but are not limited to:

•Identifying actionable biomarkers (inflammatory molecules, immune cells, etc.) that link aging and cancer risk, including in younger individuals with early onset cancers and those with genetic predispositions, and underlying mechanisms.

•Dissecting the effects of the aging tumor microenvironment (e.g., inflammation, immune system, senescent cells) on tumorigenesis, progression, and treatment response.

•Investigating how progression of age-related clonal hematopoiesis, myeloid skewing, or emergency myelopoiesis promotes hematological malignancies (including chronic myelomonocytic leukemia) or solid tumors, and/or causes therapeutic resistance.

•Establishing the effects of tumors and cancer therapies in organismal aging, including the identification of biomarkers and therapeutic strategies to minimize or prevent cancer-induced aging.

•Providing preclinical and mechanistic validation for aging-specific, anticancer therapeutic approaches based on strategies targeting inflammation or senescence, or nominated from clinical trial data segregated by age.

•Supporting exploratory clinical trials to treat or prevent cancer in older or high-risk individuals, including correlative analyses from clinical samples derived from relevant trials. We encourage collaborations with biopharma or other funding sources to accelerate the proposed work.

https://www.waxmaninstitute.org/our-research/grant-opportunities
Gates Foundation: Estimating the Global Burden of Diarrheal Diseases  Amount: Up to $1.5M over 2 years  Deadline: June 16, 2026 

Eligibility:
We welcome proposals from:

• LMIC-based institutions

• Partnerships led by LMIC institutions

• Global consortia that include meaningful LMIC partner engagement and capacity development

About: Through this Grand Challenge, the Foundation seeks to support organizations with strong epidemiologic and quantitative modeling capabilities to produce credible, transparent, and decision-useful estimates of diarrheal disease burden in LMICs. Applicants should propose approaches that can generate a minimum core set of estimates for the year 2025 and, where feasible, build longer-term analytic capacity in LMICs.

Proposals must include plans to generate, at minimum:

•Country-specific estimates of total diarrheal mortality burden in children under five.

•Country-specific pathogen-attributed mortality burden for children under five.

•Estimates reported as both total number of diarrhea-attributed deaths, pathogenspecific fractions, and mortality incidence rates, centered on 2025, using the most recent available data and appropriate methods for projection, interpolation, or extrapolation where needed.

•When possible, country-specific estimates of total and/or pathogen-attributed morbidity burden, measured as all cause or pathogen-specific disease cases, severe disease cases, or hospitalizations and presented as the total numbers, pathogenspecific fractions, and/or incidence rates.

•Estimates reported as point estimates with confidence/uncertainty intervals.

•Geographic scope: may include proposed estimates for a single country, region, all LMICs, or global. While proposals may focus on a single country, region, all LMICs, or global estimates, preference will be given to proposals focused on geographies where diarrheal mortality is expected to be highest or where improved estimates of both mortality and morbidity would have particularly high programmatic relevance, including but not limited to India, Nigeria, and sub-Saharan Africa.

https://gcgh.grandchallenges.org/sites/default/files/files/global_burden_of_diarrheal_diseases_rfp.pdf
The Helen Hay Whitney Foundation: 2026 Postdoctoral Fellowships Amount: $229,500 over 3 years Deadline: June 16, 2026

Eligibility:

•Have received a Ph.D. (or D.Phil. or equivalent) degree no more than 2 years before the application deadline, or an M.D. (or M.D.-Ph.D.) degree no more than four years before the deadline
•They have been employed in their postdoctoral laboratory for no more than 1 year before the application deadline.
•The Foundation will not make more than one award per year for training with a given supervisor. Should we receive more than one application from a single laboratory, we will review only one, as chosen by the Chair of the SAC, and decline the other(s) administratively. We urge the heads of laboratories to make this choice for us.

About: Supports early postdoctoral research training in all basic biomedical sciences. To attain its ultimate goal of increasing the number of imaginative, well- trained and dedicated medical scientists, the Foundation grants financial support of sufficient duration to help further the careers of young men and women engaged in biological or medical research.  Research Fellowship – The Helen Hay Whitney Foundation
Crohn’s & Colitis Foundation Litwin IBD Pioneers Amount: Up to $130,000 over 1 year

Deadline:
•LOI due June 23, 2026
•Full proposal due July 23, 2026

Eligibility:

•The applicant who wishes to take on the Principal Investigator position must have a faculty appointment at the institution
•Proposal must be relevant to IBD, which includes  Crohn’s disease and/or ulcerative colitis
•Only one application is allowed per applicant per submission date
•Simultaneous submission of the same application for other awards is not permitted

About: Supports innovative clinical and translational research projects with the potential to impact the treatment of IBD patients in the near future. The program encourages novel research into the diagnosis, identification of clinically relevant subsets, treatments, and cures for inflammatory bowel diseases (IBD) and funds innovative pilot research so that scientists can test their initial ideas and generate preliminary data. https://www.crohnscolitisfoundation.org/research/grants-fellowships/litwin-ibd-pioneers
Crohn’s & Colitis Foundation Career Development Awards Amount: $307,500 over 3 years Deadline:
•LOI due June 23, 2026
•Full proposal due July 23, 2026

Eligibility:

•Individuals who are already well established in the field of IBD research are not considered eligible for this award.
•Applicants should identify a senior investigator to act as a mentor to facilitate the transition to independence.
•Applicants must hold an MD and/or PhD (or equivalent degree).
oCandidates holding MD degrees must have 5 years of experience after receiving their terminal degree—two years of which must be documented research experience relevant to IBD.
oApplicants holding PhDs must have at least 2 years of documented post-doctoral research relevant to IBD.
•Generally, candidates should not be in excess of 10 years beyond the attainment of their doctoral degree.

About: Supports the development of individuals with research potential to prepare for a career of independent basic research investigation in the area of inflammatory bowel disease (IBD). https://www.crohnscolitisfoundation.org/research/grants-fellowships/career-development-awards
Crohn’s & Colitis Foundation Research Fellowship Award Amount: Up to $210,000 over 3 years Deadline:
•LOI due June 23, 2026
•Full proposal due July 23, 2026

Eligibility:

•Individuals who are already well established in the field of IBD research are not considered eligible for this award.

•Applicants should identify a senior investigator to serve as a mentor throughout the term of the award.

•Applicants must hold an MD and/or PhD (or equivalent degree).
oCandidates holding MD degrees must have 2 years of experience after receiving their terminal degree —1 year of which must be documented research experience relevant to IBD.
oApplicants holding PhDs must have at least 1 year of documented post-doctoral research relevant to IBD. MD applicants in excess of 7 years and PhD applicants in excess of 5 years of receiving their terminal degree should explain how additional support in the post-doctoral phase would benefit their development beyond their current training.

•Proposals MUST be relevant to IBD (Crohn’s Disease or ulcerative colitis) and must include a training and a mentoring plan. Only one application is allowed per applicant per submission date. Simultaneous submission of a Senior Research Award and a Research Training Award is not permitted.

•Awardees must devote a minimum of 80% of his/her professional time directly to the project

About: Supports individuals in the post-doctoral phase of their career, to develop skills related to basic research investigation in the field of inflammatory bowel disease (IBD), or Crohn’s disease and ulcerative colitis. https://www.crohnscolitisfoundation.org/research/grants-fellowships/research-fellowship-awards

GCO Funding Opportunities

Monthly and continuous submission funding opportunity packets are available on the GCO Funding Opportunities web page.

STAY CONNECTED

Sign up for the Research Listserv to stay up to date with the latest news and events.

Research 411 Portal

Still Need Help?